Junming Hu

Junming Hu

Auto-generated profile, based on publicly available information

Junming Hu

Bioinformatics Program, Boston University, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJenna L. Libera
Jenna L. Libera
JHJunming Hu
Junming Hu
TNTuyet-Anh Nguyen
Tuyet-Anh Nguyen
ZWZihan Wang
Zihan Wang
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
BWBenjamin Wolozin
Benjamin Wolozin
Dysregulated RNA metabolism is a significant feature of Alzheimer’s disease (AD), yet how post-transcriptional RNA modifications like N 6 -methyladenosine (m 6 A) are altered in AD is unknown. Here, we performed d eamination a djacent to R NA modification targets (DART-seq) on human dorsolateral prefrontal cortices to assess changes in m 6 A with nucleotide resolution. In non-AD brains, m 6 A sites increased with age, predominantly within the 3′UTR of transcripts encoding tripartite synapse proteins. In contrast, AD brains lost the age-associated m 6 A site increase and exhibited global hypomethylation of transcripts, including MAPT and APP . Hypomethylated genes involved with GABAergic signaling, glutamate transport, and ubiquitin-mediated proteolysis exhibited reduced expression, connecting m 6 A to synaptic excitotoxicity and disrupted proteostasis in AD. Site-specific m 6 A levels were linked with GABRA1 expression and protein levels, but this relationship was abolished in AD. Our findings provide insight into post-transcriptional mechanisms of dysregulated RNA metabolism in AD that are related to aging and GABAergic regulation. HIGHLIGHTS: With age, the number of m 6 A sites increases among Control cases (lacking AD pathology) but remains unchanged in AD cases. Transcripts are globally hypomethylated in AD cases. Hypomethylation is linked to decreased mRNA expression of transcripts related to synaptic and proteostatic function in AD. 3’UTR-localized m 6 A sites lack typical association with transcript metabolism of GABRA1 in AD. Graphical

22 June 2026 in BMJ Health & Care Informatics
Verified
Journal Article
Open access
JHJunming Hu
Junming Hu
SLSimon Lu
Simon Lu
QZQi Zhang
Qi Zhang
KQKehan Qian
Kehan Qian
HRHabbiburr Rehman
Habbiburr Rehman
XZXiaoling Zhang
Xiaoling Zhang
Objectives: Social determinants of health (SDOH) may improve Alzheimer’s disease (AD) risk prediction by capturing upstream contextual risk beyond routinely measured clinical variables. We aimed to develop and validate an accurate, interpretable machine-learning pipeline for AD risk prediction in UK Biobank using routinely collected data. Methods: Using data from 13 076 participants in the UK Biobank, we developed an automated machine-learning pipeline for AD risk prediction with feature selection and a C5.0 boosted-tree classifier. Data were split into training, development and test sets (7:2:1); missing values were imputed in the training data only, and feature selection, tuning and threshold calibration were performed using the training/development data, with final evaluation on the independent test set. Internal validation used repeated subsampling without replacement. Results: During up to 16 years of follow-up, 927 participants developed AD. Feature selection reduced 3590 variables to 26 predictors spanning age, APOE4, SDOH, medical history and routine clinical measures. The final model showed good discrimination (area under the precision–recall curve 0.89) and adequate calibration (Hosmer-Lemeshow p=0.71), with stable performance under repeated subsampling. Sex-stratified models showed similar patterns. Discussion: SDOH contributed useful predictive information, but their associations should be interpreted as predictive rather than causal and may reflect socioeconomic confounding and healthcare access. Conclusions: This model could support scalable AD risk screening using routinely collected data, but external validation and recalibration in non-UK populations are needed before broader application.